Search results
University of Oklahoma Health Sciences Center, Oklahoma City, OK Postdoc Fellow 2016 Pathology Select Publications: Hannafon BN, Cai A, Calloway CL, Xu YF, Zhang R, Fung KM, Ding WQ. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
Associate of Arts (AA) Interior Design. View Valerie Traynor’s profile on LinkedIn, the world’s largest professional community. Valerie has 2 jobs listed on their profile.
- 500+
- 2.1K
- OakTree IT
- Oklahoma City, Oklahoma, United States
Affiliations. 1 Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States. 2 Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States. Electronic address: Min-Li@ouhsc.edu. PMID: 34929489.
Billie Lee Turner II (born December 22, 1945, Texas City, Texas) is an American geographer and human-environmental scientist, member of the National Academy of Sciences [1] and other honorary institutions. Prominent among the third generation of the Berkeley School of Latin Americanist Geography and cultural ecological research, he has been a ...
The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America. gynecologic cancer, breast cancer, microRNAs, extracellular vesicles, exosomes, chemotherapy resistance, cancer prevention, drug development, immunotherapy, CAR-T therapy. View full biography.
Neurosurgery. If you and your neurosciences (neurology, neurosurgery) care team identify neurosurgery as an option to treat your particular health condition, you can take advantage of the comprehensive, personalized neurosurgical services at OU Health in Oklahoma City, Edmond and Tulsa.
The University of Oklahoma Health Sciences Center Stanton L. Young Biomedical Research Center, BRC1262A 975 NE 10th Street, Oklahoma City, OK 73104 USA. 405-271-1796. Min-Li@ouhsc.edu. The major goal of my research is to study the pancreatic cancer (PC) pathogenesis and develop new therapies.
